Hovig E - Search Results

1

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.

Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA. Namløs HM, et al. Among authors: hovig e. BMC Cancer. 2017 Jan 6;17(1):29. doi: 10.1186/s12885-016-2992-8. BMC Cancer. 2017. PMID: 28061772 Free PMC article.

2

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.

Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O. Maelandsmo GM, et al. Among authors: hovig e. Br J Cancer. 1995 Aug;72(2):393-8. doi: 10.1038/bjc.1995.344. Br J Cancer. 1995. PMID: 7640224 Free PMC article.

3

p53 abnormalities in different subtypes of human sarcomas.

Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL, et al. Andreassen A, et al. Among authors: hovig e. Cancer Res. 1993 Feb 1;53(3):468-71. Cancer Res. 1993. PMID: 8425179

4

Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.

Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O. Maelandsmo GM, et al. Among authors: hovig e. Cancer Res. 1996 Dec 1;56(23):5490-8. Cancer Res. 1996. PMID: 8968106

5

Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.

Maelandsmo GM, Flørenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. Maelandsmo GM, et al. Among authors: hovig e. Int J Cancer. 1997 Aug 22;74(4):464-9. doi: 10.1002/(sici)1097-0215(19970822)74:4<464::aid-ijc19>3.0.co;2-9. Int J Cancer. 1997. PMID: 9291441

6

Expression of a novel factor in human breast cancer cells with metastatic potential.

Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O. Ree AH, et al. Among authors: hovig e. Cancer Res. 1999 Sep 15;59(18):4675-80. Cancer Res. 1999. PMID: 10493524

7

[Gene therapy in cancer].

Hovig E, Myklebost O, Aamdal S, Smeland EB. Hovig E, et al. Tidsskr Nor Laegeforen. 2001 Feb 10;121(4):482-8. Tidsskr Nor Laegeforen. 2001. PMID: 11255868 Review. Norwegian.

8

Analysis of repeatability in spotted cDNA microarrays.

Jenssen TK, Langaas M, Kuo WP, Smith-Sørensen B, Myklebost O, Hovig E. Jenssen TK, et al. Among authors: hovig e. Nucleic Acids Res. 2002 Jul 15;30(14):3235-44. doi: 10.1093/nar/gkf441. Nucleic Acids Res. 2002. PMID: 12136105 Free PMC article.

9

MArray: analysing single, replicated or reversed microarray experiments.

Wang J, Nygaard V, Smith-Sørensen B, Hovig E, Myklebost O. Wang J, et al. Among authors: hovig e. Bioinformatics. 2002 Aug;18(8):1139-40. doi: 10.1093/bioinformatics/18.8.1139. Bioinformatics. 2002. PMID: 12176840

10

Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance.

Nygaard V, Løland A, Holden M, Langaas M, Rue H, Liu F, Myklebost O, Fodstad Ø, Hovig E, Smith-Sørensen B. Nygaard V, et al. Among authors: hovig e. BMC Genomics. 2003 Mar 23;4(1):11. doi: 10.1186/1471-2164-4-11. Epub 2003 Mar 23. BMC Genomics. 2003. PMID: 12659661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters